CDR2 Activators
The cellular environment teems with intricate signaling pathways and interactions, making the modulation of proteins like CDR2 complex yet vital. The array of chemicals linked to CDR2's activity primarily centers on chromatin modifications and various signaling pathways. Agents such as 5-Azacytidine, Trichostatin A, and Vorinostat underline the profound impact chromatin and DNA structure alterations can have on protein activity, including that of CDR2. Further broadening this spectrum are proteasome inhibitors like MG-132, which emphasize the intricate balance of protein synthesis and degradation in influencing protein functions.
A deep dive into the intricate web of cellular pathways shines light on the role of inhibitors targeting the likes of PI3K, p38 MAPK, MEK, and mTOR. Chemicals such as LY294002, SB203580, PD98059, and Rapamycin not only showcase the significance of these pathways but also elucidate their potential role in modulating CDR2 activity. The role of methylation in protein function is brought to the forefront by agents like UNC0638 and 3-Deazaneplanocin A. Bromodomain inhibition through JQ1 further complements this landscape, highlighting the vast network of cellular interactions that can influence CDR2.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor. By modifying DNA methylation, it can modulate gene expression, possibly affecting CDR2. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor. Modifying chromatin structure can influence CDR2 activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor. By affecting chromatin remodeling, it can influence CDR2's function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor. By stabilizing proteins, it can affect CDR2 levels or associated partners. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
HDAC inhibitor. Modifying chromatin structure can influence CDR2 function. | ||||||
PF 4708671 | 1255517-76-0 | sc-361288 sc-361288A | 10 mg 50 mg | $179.00 $700.00 | 9 | |
G9a/GLP inhibitor. Modifying histone methylation can influence CDR2 activity. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Bromodomain inhibitor. Influencing bromodomain-containing proteins can modulate CDR2 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor. By modulating PI3K/Akt pathway, it can influence CDR2's function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor. Through MAPK pathway modulation, it can affect CDR2. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor. Influencing the MAPK/ERK pathway can modulate CDR2 activity. | ||||||